Key Financial Data Of Group

Oncolys BioPharma Inc. - Filing #7727011

Concept As at
2018-03-31
2018-01-01 to
2018-03-31
As at
2017-12-31
2017-01-01 to
2017-12-31
2017-01-01 to
2017-03-31
As at
2017-03-31
Key financial data of group
Business results of group
Net sales
33,874,000 JPY
229,139,000 JPY
15,380,000 JPY
Ordinary profit (loss)
-310,439,000 JPY
-1,087,185,000 JPY
-241,578,000 JPY
Net assets
2,596,831,000 JPY
2,931,893,000 JPY
2,712,717,000 JPY
Total assets
3,148,825,000 JPY
3,526,222,000 JPY
3,174,613,000 JPY
Basic earnings (loss) per share
-28.09
-106.23
-25.91
Diluted earnings per share
Equity-to-asset ratio
0.821 xbrli:pure
0.829 xbrli:pure
0.849 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.